Spectrum Pharmaceuticals is a biotechnology company with integrated commercial and drug development operations. SPPI has three oncology products on the market, two for different types of non-Hodgkin’s lymphoma and one for advanced metastatic colorectal cancer, as well as two drugs in late-stage development and a diverse pipeline. The company has also established a network of worldwide partners. For more information, visit the company’s Web site: http://www.spectrumpharm.com
Let us hear your thoughts below:
